Generic
Dantrolene Sodium

Description
Relaxo 25 is a medication formulated with Dantrolene Sodium, a skeletal muscle relaxant used to treat chronic spasticity and malignant hyperthermia. Manufactured by Ziska Pharmaceuticals Limited, it ensures reliable quality and efficacy for various therapeutic needs.

Benefits
Relaxo 25 alleviates spasticity caused by upper motor neuron disorders, enhances functional rehabilitation, and helps prevent malignant hyperthermic episodes during surgical procedures. It offers relief and aids in the management of painful muscle stiffness.

Ingredients
Each capsule contains 25mg of Dantrolene Sodium as the active ingredient, supported by inert excipients ensuring stability and effectiveness.

Uses and Doses
Relaxo 25 is used in the treatment of chronic spasticity and malignant hyperthermia. For adults, initial doses of 25mg twice daily are titrated gradually, with a maximum daily dose of 400mg. Pediatric dosing begins at 0.5mg/kg, with adjustments as needed.

Side Effects
Common side effects include drowsiness, dizziness, fatigue, diarrhea, and general malaise. Symptoms are usually transient and can be minimized by gradual dose escalation. Severe diarrhea may require discontinuation of the therapy.

How to Use
Take Relaxo 25 orally as prescribed, with or without food. Follow your doctor's instructions carefully regarding dosage and frequency. Do not exceed the recommended dose.

Pregnancy & Lactation
Dantrolene is classified under Pregnancy Category C and should only be used if the benefits outweigh potential risks to the fetus. It is not recommended for nursing mothers.

Precautions and Warnings
Monitor liver function during long-term use to avoid hepatotoxicity. Discontinue therapy if there is no observable benefit within 45 days. Avoid combining with CNS depressants.

Safety Information
Do not use Relaxo 25 if you have active hepatic conditions like hepatitis or cirrhosis. Ensure you consult a healthcare professional before starting therapy.

Indications
Relaxo 25 is indicated for managing spasticity due to upper motor neuron disorders and preventing malignant hyperthermia in surgical patients.

Pharmacology
Dantrolene reduces skeletal muscle contractions by disrupting excitation-contraction coupling, targeting calcium release within the sarcoplasmic reticulum.

Therapeutic Class
Centrally acting skeletal muscle relaxants.

Storage Conditions
Store in a cool, dry, and light-protected place.

3 FAQ

1. What conditions does Relaxo 25 treat?
   It is used for chronic spasticity and malignant hyperthermia management.
2. Can Relaxo 25 be used during pregnancy?
   Only if the benefits outweigh the potential risks, as it is a Category C medication.
3. What are the common side effects of Relaxo 25?
   Drowsiness, dizziness, fatigue, and diarrhea are common but usually transient.

Disclaimer
The information provided about Relaxo 25 (Dantrolene Sodium 25mg) is for educational purposes only and should not replace professional medical advice. Always consult a licensed healthcare provider for diagnosis, treatment, or prescription guidance tailored to your specific medical needs. Ziska Pharmaceuticals Limited and its representatives are not responsible for any misuse or adverse effects caused by improper use of this medication. Ensure to follow all recommendations and precautions as advised by your doctor or pharmacist.

keywords: Relaxo 25, Dantrolene Sodium, muscle relaxant, chronic spasticity, malignant hyperthermia, skeletal muscle relaxant, Ziska Pharmaceuticals, muscle stiffness relief, motor neuron disorders, spasticity treatment, calcium release inhibitor, hepatotoxicity warning, CNS depressants interaction, muscle relaxant therapy, spasticity medication, pediatric spasticity treatment, anesthesia preparation, surgical muscle relaxant, Dantrolene capsules, Relaxo medication.